Schedule 13D ownership disclosure

TURNSTONE BIOLOGICS CORP

Common Stock, $0.001 par value per share · CUSIP: 90042W100

Event date: 2025-08-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Versant Venture Capital V, L.P.Reported CIK 0001589097

    Shares: 0 · Class: 0.0%

  • Versant Affiliates Fund V, L.P.Reported CIK 0001589095

    Shares: 0 · Class: 0.0%

  • Versant Ophthalmic Affiliates Fund I, L.P.Reported CIK 0001589098

    Shares: 0 · Class: 0.0%

  • Versant Ventures V, LLCReported CIK 0001619298

    Shares: 0 · Class: 0.0%

  • Versant Venture Capital V (Canada) LPReported CIK 0001612235

    Shares: 0 · Class: 0.0%

  • Versant Ventures V GP-GP (Canada), Inc.Reported CIK 0001619297

    Shares: 0 · Class: 0.0%

  • Versant Ventures V (Canada), L.P.Reported CIK 0001716490

    Shares: 0 · Class: 0.0%

  • Versant Vantage II, L.P.Reported CIK 0001832235

    Shares: 0 · Class: 0.0%

  • Versant Vantage II GP, L.P.Reported CIK 0001839790

    Shares: 0 · Class: 0.0%

  • Versant Vantage II GP-GP, LLCReported CIK 0001839789

    Shares: 0 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-107414
Form type
SCHEDULE 13D/A
Filer
Turnstone Biologics Corp.
CIK
CIK 1764974
Filed
Aug 12, 2025
Reporting period
Aug 08, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub